OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms governing antifungal drug resistance
Yunjin Lee, Nicole Robbins, Leah E. Cowen
npj Antimicrobials and Resistance (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

An Overview of the Recent Advances in Antimicrobial Resistance
Manuela Oliveira, Wilson Antunes, Salete Mota, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1920-1920
Open Access | Times Cited: 19

Isobavachalcone exhibits antifungal and antibiofilm effects against C. albicans by disrupting cell wall/membrane integrity and inducing apoptosis and autophagy
Weidong Qian, Jiaxing Lu, Chang Gao, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 10

Molecular Diagnostics for Invasive Fungal Diseases: Current and Future Approaches
David Pham, Varsha Sivalingam, Helen M. Tang, et al.
Journal of Fungi (2024) Vol. 10, Iss. 7, pp. 447-447
Open Access | Times Cited: 9

Synthesis and antimicrobial evaluation of a new hybrid bis-cyanoacrylamide-based-piperazine containing sulphamethoxazole moiety against rheumatoid arthritis-associated pathogens
Mona M. Soliman, Ahmed H. M. Elwahy, Ahmed M. Sayed, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access | Times Cited: 1

The Significance of Mono‐ and Dual‐Effective Agents in the Development of New Antifungal Strategies
Cengiz Zobi, Öztekin Algül
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 1
Open Access | Times Cited: 1

Molecular basis of the inositol deacylase PGAP1 involved in quality control of GPI-AP biogenesis
Jingjing Hong, Tingting Li, Yulin Chao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6

Etiopathology, Epidemiology, Diagnosis, and Treatment of Fungal Keratitis
Amol Chhatrapati Bisen, Sachin Nashik Sanap, Sristi Agrawal, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 7, pp. 2356-2380
Closed Access | Times Cited: 6

Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness cost
Camille Bédard, Isabelle Gagnon‐Arsenault, Jonathan Boisvert, et al.
Nature Microbiology (2024) Vol. 9, Iss. 11, pp. 3025-3040
Closed Access | Times Cited: 6

The Role of Olorofim in the Treatment of Filamentous Fungal Infections: A Review of In Vitro and In Vivo Studies
Aliosha Feuss, Marie‐Elisabeth Bougnoux, Éric Dannaoui
Journal of Fungi (2024) Vol. 10, Iss. 5, pp. 345-345
Open Access | Times Cited: 5

Unveiling the menace: a thorough review of potential pandemic fungal disease
Mahdi Jafarlou
Frontiers in Fungal Biology (2024) Vol. 5
Open Access | Times Cited: 4

Resistance Mechanisms of Plant Pathogenic Fungi to Fungicide, Environmental Impacts of Fungicides, and Sustainable Solutions
Tarequl Islam, Mohd Danishuddin, Noshin Tabassum Tamanna, et al.
Plants (2024) Vol. 13, Iss. 19, pp. 2737-2737
Open Access | Times Cited: 4

Unraveling the Therapeutic Potential of Antifungal Metabolites of Aspergillus giganteus on Human Fungal Pathogen
Karthiga Sivarajan, Ramya Ravindhiran, Jothi Nayaki Sekar, et al.
Indian Journal of Microbiology (2025)
Closed Access

Candidozyma auris Alert in South America: An Epidemiological and Therapeutic Update
Gabriel Davi Marena, Joshua D. Nosanchuk, Carlos P. Taborda
Current Tropical Medicine Reports (2025) Vol. 12, Iss. 1
Closed Access

Gelatin Nanoemulsion-Based Co-Delivery of Terbinafine and Essential Oils for Treatment of Candida albicans Biofilms
Muhammad Aamir Hassan, Sàdaf Noor, Jungmi Park, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 127-127
Open Access

Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
Jemma Taitz, Jian Tan, Duan Ni, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

The evolution of antifungal therapy: traditional agents, current challenges and future perspectives
Cássia Milena de Souza, Bárbara Tavares Bezerra, Daniel Agreda Mellon, et al.
Current Research in Microbial Sciences (2025) Vol. 8, pp. 100341-100341
Open Access

Macrophomina phaseolina: A Phytopathogen Associated with Human Ocular Infections—A Case Report of Endophthalmitis and Systematic Review of Human Infections
Panagiotis Toumasis, Georgia Vrioni, Ioanna Gardeli, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 430-430
Open Access

Antibiofilm Activity of Protamine Against the Vaginal Candidiasis Isolates of Candida albicans, Candida tropicalis and Candida krusei
Sivakumar Jeyarajan, Indira Kandasamy, Raja Veerapandian, et al.
Applied Biosciences (2025) Vol. 4, Iss. 1, pp. 5-5
Open Access

The stress-protectant molecule trehalose mediates fluconazole tolerance in Candida glabrata
Qingjuan Zhu, Stefanie Wijnants, Regina Feil, et al.
Antimicrobial Agents and Chemotherapy (2025)
Open Access

Advances in Coordination Chemistry of Schiff Base Complexes: A Journey from Nanoarchitectonic Design to Biomedical Applications
Ahmad Abd‐El‐Aziz, Zexuan Li, Xinyue Zhang, et al.
Topics in Current Chemistry (2025) Vol. 383, Iss. 1
Closed Access

Potable water as a source of intermediate and borderline-resistant Aspergillus and Candida strains
Monika Novak Babič, Nina Gunde‐Cimerman
Journal of Water and Health (2025) Vol. 23, Iss. 2, pp. 225-237
Open Access

Fungal Metabolites in Defense
Marija Ivanov, Dejan Stojković, Marina Sokóvić
(2025), pp. 133-149
Closed Access

Page 1 - Next Page

Scroll to top